 Lipoproteins
"Lipoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes.
| Descriptor ID |
D008074
|
| MeSH Number(s) |
D10.532 D12.776.521
|
| Concept/Terms |
Lipoproteins- Lipoproteins
- Lipoprotein
- Circulating Lipoproteins
- Lipoproteins, Circulating
|
Below are MeSH descriptors whose meaning is more general than "Lipoproteins".
Below are MeSH descriptors whose meaning is more specific than "Lipoproteins".
This graph shows the total number of publications written about "Lipoproteins" by people in this website by year, and whether "Lipoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 3 | 0 | 3 | | 1991 | 1 | 1 | 2 | | 1992 | 4 | 1 | 5 | | 1993 | 0 | 1 | 1 | | 1997 | 1 | 2 | 3 | | 1998 | 5 | 2 | 7 | | 1999 | 3 | 2 | 5 | | 2000 | 4 | 2 | 6 | | 2001 | 1 | 0 | 1 | | 2002 | 0 | 2 | 2 | | 2003 | 3 | 4 | 7 | | 2004 | 0 | 2 | 2 | | 2005 | 1 | 4 | 5 | | 2006 | 1 | 2 | 3 | | 2007 | 2 | 6 | 8 | | 2008 | 4 | 1 | 5 | | 2009 | 0 | 2 | 2 | | 2010 | 2 | 7 | 9 | | 2011 | 0 | 4 | 4 | | 2012 | 1 | 3 | 4 | | 2013 | 5 | 2 | 7 | | 2014 | 2 | 3 | 5 | | 2015 | 5 | 2 | 7 | | 2016 | 2 | 3 | 5 | | 2017 | 4 | 1 | 5 | | 2018 | 2 | 1 | 3 | | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lipoproteins" by people in Profiles.
-
Pirim D, Radwan ZH, Wang X, Niemsiri V, Hokanson JE, Hamman RF, Feingold E, Bunker CH, Demirci FY, Kamboh MI. Apolipoprotein E-C1-C4-C2 gene cluster region and inter-individual variation in plasma lipoprotein levels: a comprehensive genetic association study in two ethnic groups. PLoS One. 2019; 14(3):e0214060.
-
Yalamanoglu A, Deuel JW, Hunt RC, Baek JH, Hassell K, Redinius K, Irwin DC, Schaer DJ, Buehler PW. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease. Am J Physiol Lung Cell Mol Physiol. 2018 11 01; 315(5):L765-L774.
-
Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab. 2018 09; 15:45-55.
-
El Kasmi KC, Vue PM, Anderson AL, Devereaux MW, Ghosh S, Balasubramaniyan N, Fillon SA, Dahrenmoeller C, Allawzi A, Woods C, McKenna S, Wright CJ, Johnson L, D'Alessandro A, Reisz JA, Nozik-Grayck E, Suchy FJ, Sokol RJ. Macrophage-derived IL-1ß/NF-?B signaling mediates parenteral nutrition-associated cholestasis. Nat Commun. 2018 04 11; 9(1):1393.
-
Yu T, Sungelo MJ, Goldberg IJ, Wang H, Eckel RH. Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins. Horm Metab Res. 2017 May; 49(5):400-406.
-
Wang Z, Manichukal A, Goff DC, Mora S, Ordovas JM, Pajewski NM, Post WS, Rotter JI, Sale MM, Santorico SA, Siscovick D, Tsai MY, Arnett DK, Rich S, Frazier-Wood AC. Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA). Hum Genet. 2017 06; 136(6):715-726.
-
Dowdell AS, Murphy MD, Azodi C, Swanson SK, Florens L, Chen S, Zückert WR. Comprehensive Spatial Analysis of the Borrelia burgdorferi Lipoproteome Reveals a Compartmentalization Bias toward the Bacterial Surface. J Bacteriol. 2017 03 15; 199(6).
-
Damen MS, Agca R, Holewijn S, de Graaf J, Dos Santos JC, van Riel PL, Fransen J, Coenen MJ, Nurmohamed MT, Netea MG, Dinarello CA, Joosten LA, Heinhuis B, Popa CD. IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis. Sci Rep. 2017 01 30; 7:41629.
-
Taha DA, Zgair A, Lee JB, de Moor CH, Barrett DA, Bruce KD, Sungelo M, Eckel RH, Gershkovich P. Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity. Eur J Pharm Sci. 2017 Mar 30; 100:163-175.
-
Moriarty PM, Parhofer KG, Babirak SP, Cornier MA, Duell PB, Hohenstein B, Leebmann J, Ramlow W, Schettler V, Simha V, Steinhagen-Thiessen E, Thompson PD, Vogt A, von Stritzky B, Du Y, Manvelian G. Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial. Eur Heart J. 2016 Dec 21; 37(48):3588-3595.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|